CVS Loses Challenge To Sentry’s Revamped Antitrust Suit

Sentry Data Systems Inc. can continue its lawsuit against CVS alleging the pharmacy chain is unlawfully forcing health care providers to use its 340B Drug Pricing Program administrator Wellpartner LLC, a Florida federal judge said on Wednesday…

Read this piece in its entirety at Law360.

Comments